These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 1982341)

  • 1. Diminished corticotropin and enhanced prolactin responses to 8-hydroxy-2(di-n-propylamino)tetralin in methylenedioxymethamphetamine pretreated rats.
    Poland RE
    Neuropharmacology; 1990 Nov; 29(11):1099-101. PubMed ID: 1982341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of 8-hydroxy-2-(di-n-propylamino) tetralin on rat prolactin secretion.
    Simonovic M; Gudelsky GA; Meltzer HY
    J Neural Transm; 1984; 59(2):143-9. PubMed ID: 6233394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 5-hydroxytryptamine (5-HT)1A receptors and the tail-flick response. I. 8-hydroxy-2-(di-n-propylamino) tetralin HBr-induced spontaneous tail-flicks in the rat as an in vivo model of 5-HT1A receptor-mediated activity.
    Millan MJ; Bervoets K; Colpaert FC
    J Pharmacol Exp Ther; 1991 Mar; 256(3):973-82. PubMed ID: 1826033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A central serotonin receptor agonist, 8-hydroxy-2-(di-n-propylamino)tetralin, has different effects on prolactin secretion in male and female rats.
    Carlsson M; Eriksson E
    Acta Pharmacol Toxicol (Copenh); 1986 Apr; 58(4):297-302. PubMed ID: 2940798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serotonergic modulation of rat pup ultrasonic vocal development: studies with 3,4-methylenedioxymethamphetamine.
    Winslow JT; Insel TR
    J Pharmacol Exp Ther; 1990 Jul; 254(1):212-20. PubMed ID: 1973197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stimulation of corticosterone secretion by the selective 5-HT1A receptor agonist 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) in the rat.
    Przegaliński E; Budziszewska B; Warchoł-Kania A; Błaszczyńska E
    Pharmacol Biochem Behav; 1989 Jun; 33(2):329-34. PubMed ID: 2530590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of MDL 73005EF on central pre- and postsynaptic 5-HT1A receptor function in the rat in vivo.
    Gartside SE; Cowen PJ; Hjorth S
    Eur J Pharmacol; 1990 Dec; 191(3):391-400. PubMed ID: 1964908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of serotonin receptor agonist-induced activation of the hypothalamic-pituitary-adrenal axis in the rat.
    Calogero AE; Bagdy G; Szemeredi K; Tartaglia ME; Gold PW; Chrousos GP
    Endocrinology; 1990 Apr; 126(4):1888-94. PubMed ID: 2156670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tolerance and cross-tolerance to the activating effects of 3,4-methylenedioxymethamphetamine and a 5-hydroxytryptamine1B agonist.
    Callaway CW; Geyer MA
    J Pharmacol Exp Ther; 1992 Oct; 263(1):318-26. PubMed ID: 1357158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. WAY-100635 inhibits 8-OH-DPAT-stimulated oxytocin, ACTH and corticosterone, but not prolactin secretion.
    Vicentic A; Li Q; Battaglia G; Van de Kar LD
    Eur J Pharmacol; 1998 Apr; 346(2-3):261-6. PubMed ID: 9652368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of the repeated administration of (+/-)-3,4-methylenedioxymethamphetamine on the behavioral response of rats to the 5-HT1A receptor agonist (+/-)-8-hydroxy-(di-n-propylamino)tetralin.
    Granoff MI; Ashby CR
    Neuropsychobiology; 2001 Jan; 43(1):42-8. PubMed ID: 11150898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of selective serotonin (5-HT) agonists and 5-HT2 antagonist on prolactin secretion.
    Van de Kar LD; Lorens SA; Urban JH; Bethea CL
    Neuropharmacology; 1989 Mar; 28(3):299-305. PubMed ID: 2524677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of 8-hydroxy-2-(di-n-propylamino)-tetralin on the tryptophan-induced increase in 5-hydroxytryptophan accumulation in rat brain.
    Fernstrom MH; Massoudi MS; Fernstrom JD
    Life Sci; 1990; 47(4):283-9. PubMed ID: 2143798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticonflict effect of the putative serotonin receptor agonist 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT).
    Engel JA; Hjorth S; Svensson K; Carlsson A; Liljequist S
    Eur J Pharmacol; 1984 Oct; 105(3-4):365-8. PubMed ID: 6239785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MDMA stimulus generalization to the 5-HT(1A) serotonin agonist 8-hydroxy-2- (di-n-propylamino)tetralin.
    Glennon RA; Young R
    Pharmacol Biochem Behav; 2000 Jul; 66(3):483-8. PubMed ID: 10899359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complex actions of serotonergic agonists on cold-stimulated TSH secretion in male rats.
    Toivonen M; Männistö PT
    Eur J Pharmacol; 1990 May; 180(1):91-102. PubMed ID: 2142094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Failure to antagonize the 8-hydroxy-2-di-n-propylamino)tetralin-induced facilitation of male rat sexual behavior by the administration of 5-HT receptor antagonists.
    Ahlenius S; Larsson K
    Eur J Pharmacol; 1984 Apr; 99(4):279-86. PubMed ID: 6234182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alterations in 8-hydroxy-2-(dipropylamino)tetralin-induced neuroendocrine responses after 5,7-dihydroxytryptamine-induced denervation of serotonergic neurons.
    Van de Kar LD; Li Q; Cabrera TM; Brownfield MS; Battaglia G
    J Pharmacol Exp Ther; 1998 Jul; 286(1):256-62. PubMed ID: 9655867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. (+)-cis-8-Hydroxy-1-methyl-2-(di-n-propylamino)tetralin: a potent and highly stereoselective 5-hydroxytryptamine receptor agonist.
    Arvidsson LE; Johansson AM; Hacksell U; Nilsson JL; Svensson K; Hjorth S; Magnusson T; Carlsson A; Andersson B; Wikström H
    J Med Chem; 1987 Nov; 30(11):2105-9. PubMed ID: 2959776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The behavioural, but not the hypothermic or corticosterone, response to 8-hydroxy-2-(DI-n-propylamino)-tetralin, is antagonized by NAN-190 in the rat.
    Przegaliński E; Ismaiel AM; Chojnacka-Wójcik E; Budziszewska B; Tatarczyńska E; Błaszczyńska E
    Neuropharmacology; 1990 Jun; 29(6):521-6. PubMed ID: 2143565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.